# Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

> **NCT01475123** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Kumamoto University** · enrollment: 268 (actual)

## Conditions studied

- Coronary Artery Disease
- End Stage Renal Disease

## Interventions

- **DRUG:** Nicorandil

## Key facts

- **NCT ID:** NCT01475123
- **Lead sponsor:** Kumamoto University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-06
- **Primary completion:** 2011-06
- **Final completion:** 2026-03
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475123, "Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01475123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*